The Senate will consider Mr. Azar’s nomination Jan. 9. If approved, Mr. Azar will join the Trump administration after 10 years at pharmaceutical company Eli Lilly, where he served the latter half of his tenure as president of the U.S. division. Mr. Azar also has a background in politics and policy, clerking for the late Justice Antonin Scalia and later serving two terms as general counsel of HHS under President George W. Bush.
“Mr. Azar’s years of experience in both the private and public sectors equips him well to effectively lead this complex agency,” said FAH President and CEO Chip Khan in a statement. “We encourage the U.S. Senate to confirm Mr. Azar quickly. We look forward to working with him on further improving American healthcare delivery and financing.”
More articles on leadership and management:
Idaho governor signs order to loosen ACA restrictions, offer lower-cost plans
New book claims Trump proposed Medicare-for-all in beginning of presidency
Trump to receive, allegedly publicize results of medical exam this week: 6 things to know
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.
